Palo Alto, CA – Agilent Technologies has completed the acquisition of Silicon Genetics, a provider of software solutions for life science discovery. Agilent and Silicon Genetics had announced an acquisition agreement in August. Financial details of the agreement were not disclosed.
Silicon Genetics has customers including more than 600 pharmaceutical companies, academic institutions and major research organizations around the world. With the addition of Silicon Genetics’ genomics data analysis and management tools to its portfolio, Agilent says it is significantly boosting its presence in life science informatics.
The companies together plan to create products spanning DNA, RNA, protein and pathway applications. The team will sell and support the products developed by Silicon Genetics, the Rosetta Resolver and Luminator gene expression data analysis systems, the Agilent Spectrum Mill proteomics workbench and the Agilent Synapsia informatics workbench.
The company says that most of Silicon Genetics’ 50 employees have joined Agilent and are now part of the company’s life sciences and chemical analysis business in Santa Clara, CA.